Optilite Rheumatoid Factor Kit— 510(k) K162263

Substantially Equivalent

The Binding Site Group , Ltd.

FDA 510(k) clearance K162263 for Optilite Rheumatoid Factor Kit, Substantially Equivalent on 2017-05-03. Applicant: The Binding Site Group , Ltd..

Clearance details

Applicant
The Binding Site Group , Ltd.
Product code
Code DHR
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Birmingham, GB
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.